These effects were recently brought to light by research demonstrating that the TCF7L2 gene controls a number of processes, including adipogenesis and disorders like T2D, as a downstream effector of the Wnt/ß-catenin signaling system 69. The gene discussed is TCF7L2; the disease is type 2 diabetes mellitus.